Ober Health Center
Homa Bay, Kenya
NCT Number: NCT05482360
This study tests strategies for improving PrEP implementation in maternal and child health clinics using an interrupted time series.
Looking for future studies?
Notify Me15 year–100 year
Female
Interventional
Not applicable
Homa Bay, Kenya
This study aims to improve integrated delivery of PrEP to women seeking health services in maternal and child health clinics by piloting and evaluating four strategies or bundles of strategies for optimized PrEP delivery. Strategies to be tested include three packages of strategies identified by stakeholders.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
There were three bundles of strategies tested determined based on the qualitative information gathered in Aim 1 by stakeholders
Time frame: 6 months
Proportion of women who are screened for PrEP / total women receiving antenatal or postnatal services
Time frame: 6 months
Proportion of women who receive all PrEP specific steps in a visit: HIV testing, HIV risk screening, PrEP counseling. Assessed among the subset of women who are due for an HIV test, as per Kenyan guidelines, which is a subset of the overall sample.
Time frame: 6 months
Time (minutes) spent receiving services from health care workers
Time frame: 6 months
Time (minutes) spent waiting to receive services
Time frame: 6 months
Total on 4 item Acceptability of Intervention Measures (AIM) score, 1 (Completely disagree) to 5 (Completely Agree) Likert scale. The minimum score on the 4 items is 4 points (scoring 1 on each of the 4 items) while the maximum is 20 points (scoring 5 on each of the 4 items). A higher score indicates a better outcome. The sub-scores on each of the 4 items are summed.
Time frame: 6 months
Total on 4 item Intervention Appropriateness Measure (IAM) score, 1 (Completely disagree) to 5 (Completely Agree) Likert scale. The minimum score on the 4 items is 4 points (scoring 1 on each of the 4 items) while the maximum is 20 points (scoring 5 on each of the 4 items). A higher score indicates a better outcome. The sub-scores on each of the 4 items are summed.
Time frame: 6 months
Total on 7 item exit survey of clients to assess their satisfaction with services received at the facility, 1 (worse) to 4 (better) scale. The minimum score on the 7 items is 7 points (scoring 1 on each of the 7 items) while the maximum is 24 points (scoring 4 on each of the 7 items). A higher score indicates a better outcome. The sub-scores on each of the 4 items are summed.
Time frame: 6 months
Proportion of women who accept PrEP among those offered
Time frame: 6 months
Proportion of women who present for a refill among those initially prescribed PrEP
Time frame: 6 months
Number of participants with perfect knowledge on PrEP information questions based on content covered in counseling sessions
Time frame: 6 months
Proportion of women who have >80 percent adherence to PrEP by pill count among those initially prescribed PrEP
Time frame: 6 months
Patient flow mapping to identify more efficient client flows with fewer transitions between physical spaces and providers
University of Washington
Other
Testing Implementation Strategies to Improve Delivery of Pre-exposure Prophylaxis (PrEP) for Pregnant and Postpartum Women in Kenya (K01)
Acronym: PrEPARE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04712994
Blood-Borne Infections, Communicable Diseases
Homa Bay, Kenya
View Trial DetailsNCT06274060
Blood-Borne Infections, Communicable Diseases
Pietermaritzburg, KwaZulu-Natal, South Africa
View Trial DetailsNCT05417620
Blood-Borne Infections, Communicable Diseases
Cape Town, Western Cape, South Africa
View Trial DetailsNCT04205487
Blood-Borne Infections, Chemically-Induced Disorders
Miami, Florida, United States
View Trial Details